3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow Autonomic Dysreflexia: new trials by email Literature Review of Autonomic Dysreflexia trials Research Report on Autonomic Dysreflexia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Post-SCI Hypotension Midodrine Hydrochloride - Spinal Cord Injury, Autonomic Dysreflexia | Phase 2 / Phase 3 | Completed | James J. Peters Veterans Affairs Medical Center | 66 | 2017-06-01 | 2025-02-21 |
| The Effects of Normalizing Blood Pressure on Cerebral Blood Flow in Hypotensive Individuals With Spinal Cord Injury Midodrine Hydrochloride, Pyridostigmine Bromide, Mirabegron - Spinal Cord Injury, Autonomic Dysreflexia | Phase 2 | Completed | James J. Peters Veterans Affairs Medical Center | 21 | 2016-12-01 | 2024-10-01 |
| Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI) Fesoterodine - Autonomic Dysreflexia | Phase 2 | Completed | University of British Columbia | 15 | 2016-02-25 | 2019-09-09 |
Spinal Cord Injuries (3) · Hypotension (1) · Hypotension, Orthostatic (1)
Autonomic Nervous System Diseases (3) · Central Nervous System Diseases (3) · Nervous System Diseases (3) · Spinal Cord Diseases (3) · Trauma, Nervous System (3) · Wounds and Injuries (3) · Cardiovascular Diseases (1) · Orthostatic Intolerance (1) · Primary Dysautonomias (1) · Vascular Diseases (1)
Midodrine (2) · Pyridostigmine Bromide (1) · fesoterodine (1) · mirabegron (1)
James J. Peters Veterans Affairs Medical Center (2) · University of British Columbia (1)
United States (2) · Canada (1)
Andrei Krassioukov, MD,PhD,FRCPC (1) · Jill M Wecht, Ed.D (1) · Jill M Wecht, Ed.D. (1)